作为针对Mycobacterium结核病的新疗法,PROTACs:目前的进展和未来的方向
Deepthi Ramesh1, Ahammed Ameen Thottasseri2
1Department of Pharmaceutical Chemistry, University of California, San Francisco, 94158, USA.
European journal of medicinal chemistry
|February 27, 2026
概括
向蛋白质降解 (TPD) 提供了一种新的方法来对抗结核病,通过使用向蛋白质分解金马 (PROTACs) 来降解有害蛋白质. 这种方法有望对抗Mycobacterium tuberculosis的有效和持久的治疗方法.
科学领域:
- 药物发现 药物发现 药物发现
- 分子生物学分子生物学
- 传染性疾病 传染性疾病
背景情况:
- 向蛋白降解 (TPD) 是一种新的治疗策略.
- TPD利用细胞的无素-蛋白酶体系统来消除蛋白质.
- 这与传统的抑制剂形成鲜明对比,具有持久效果和克服耐药性的潜力.
研究的目的:
- 审查TPD的近期进展,特别是针对Mycobacterium tuberculosis的蛋白质溶解向金马 (PROTACs).
- 探索基于PROTAC的抗菌疗法降解的机遇和挑战.
- 概述PROTACs在传染病治疗中的未来方向.
主要方法:
- 审查关于TPD和PROTAC技术的当前文献.
- 对TPD相关的细菌耐药机制的分析.
- 讨论选择性挑战和药物化学方法.
主要成果:
- 在M.结核病中,PROTACs为致病性蛋白质的有针对性降解提供了一个有希望的方法.
- 了解细菌耐药机制对于PROTAC疗效至关重要.
- 在实现选择性和优化交付平台方面仍然存在挑战.
结论:
- TPD,特别是PROTACs,具有显著的潜力,可以彻底改变诸如结核病之类的传染病的治疗.
- 需要在药物化学,结构生物学和输送方面取得进一步的进展,才能充分发挥PROTACs的治疗潜力.
- PROTACs代表了向基于机制的疾病驱动蛋白质根除的范式转变.
相关概念视频
01:28Pulmonary Tuberculosis V
691
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
691
01:29Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
01:28Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
01:26Pulmonary Tuberculosis IV
575
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
575
01:31Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
01:26Targets for Drug Action: Overview
10.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.8K